Virgilio J. Cadete
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Right Ventricular Maladaptation to Pressure Overload in Fischer Rats Is Associated With Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular Energetics.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: October 24, 2022
Adaptive optimization of the OXPHOS assembly line partially compensates lrpprc-dependent mitochondrial translation defects in mice.
Journal: Communications biology
Published: October 30, 2020
Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.
Journal: Circulation research
Published: May 24, 2019
Mitochondrial quality control in the cardiac system: An integrative view.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 19, 2018
Macro- and micro-heterogeneity of lung endothelial cells: they may not be smooth, but they got the moves.
Journal: Pulmonary circulation
Published: November 24, 2017
Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.
Journal: Human molecular genetics
Published: March 24, 2017
Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system.
Journal: The Journal of physiology
Published: April 25, 2016
Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart.
Journal: BioMed research international
Published: October 23, 2014
Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury.
Journal: BioMed research international
Published: May 27, 2014
Synergistic protection of MLC 1 against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future.
Journal: Future medicinal chemistry
Published: March 19, 2013
Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart.
Journal: British journal of pharmacology
Published: March 02, 2013
Last Updated: 09/26/2026